Genzyme troubled by new contamination problems at manufacturing plant
This article was originally published in Scrip
Executive Summary
Genzyme has been hit with more contamination problems at its Allston, Massachusetts, manufacturing plant, this time involving foreign particle contamination of five of its products – Cerezyme, Fabrazyme, Myozyme, Thyrogen and Aldurazyme – which are used to treat rare, serious, and life-threatening diseases.